Latest News & Features
Europe
South Korean medical devices manufacturer Medit has prevailed in a patent infringement lawsuit brought by Danish rival 3Shape in Germany. 6 August 2020
article
Pendulum Therapeutics is a pathbreaker company in microbiome therapeutics and gut health. Ypsita Demunshi is a patent agent at Pendulum Therapeutics, where she manages the growing portfolio of patents worldwide and exhibits expertise in life sciences patent prosecution. 5 August 2020
Genetics
The US Court of Appeals for the Federal Circuit has partially lifted an injunction on 10X Genomics, but the biotech company must still pay almost $24 million for infringing a Bio-Rad patent. 4 August 2020
Americas
A former researcher at the research institute of the Nationwide Children’s Hospital in Ohio has pleaded guilty to conspiring to steal scientific trade secrets to sell in China. 3 August 2020
Americas
The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine. 3 August 2020
Americas
US authorities have seized thousands of dollars worth of counterfeit Botox injections in shipments in a Cincinnati port, the US Customs and Border Protection (CBP) office announced yesterday, July 30. 31 July 2020
Americas
Buyers of AbbVie’s arthritis treatment Humira have appealed against an Illinois judge’s decision to dismiss their class action antitrust suit to the US Court of Appeals for the Seventh Circuit. 31 July 2020
Americas
The development of CRISPR technology is showing no signs of losing momentum, and Arbor Biotechnologies is one company that is taking full advantage of this. We spoke to Kelly Morgan, senior director, head of IP and legal at the company to find out more. 31 July 2020
Americas
Jailed ‘pharma bro’ Martin Shkreli has told a US federal court he is not responsible for antitrust violations alleged by the US Federal Trade Commission. 30 July 2020
Big Pharma
Biopharmaceutical company AstraZeneca has struck a deal with Japanese pharmaceutical company Daiichi Sankyo to jointly develop and market a new medicine to treat lung, breast and other cancers. 30 July 2020